Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risk stratification in non-ST segment elevation acute coronary syndromes with special focus on recent guidelines.

A S Mathis1, P Meswani, S A Spinler

  • 1Department of Pharmacy Practice and Administration, College of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, USA. smathis@sbhcs.com

Pharmacotherapy
|November 23, 2001
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retrospective analysis of early steroid-induced adverse reactions in kidney and kidney-pancreas transplant recipients.

Transplantation proceedings·2007
Same author

The skinny on treatment of venous thromboembolism in obesity.

Journal of thrombosis and haemostasis : JTH·2005
Same author

Stress dose steroids in renal transplant patients undergoing lymphocele surgery.

Transplantation proceedings·2005
Same author

Deep vein thrombosis during rabbit antithymocyte globulin administration.

Transplantation proceedings·2005
Same author

Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases.

Transplantation proceedings·2004
Same author

Expression of PPAR, RXR isoforms and fatty acid transporting proteins in the rat and human gastrointestinal tracts.

Journal of pharmaceutical sciences·2004

Risk stratification is key for patients with unstable angina or non-ST segment elevation myocardial infarction. Identifying high-risk individuals ensures they receive prompt, aggressive treatment to prevent adverse events like heart attack and death.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Patients with unstable angina or non-ST segment elevation myocardial infarction present diverse risks.
  • Current guidelines advocate for risk stratification to guide treatment intensity.

Purpose of the Study:

  • To review risk stratification modalities for patients with unstable angina or non-ST segment elevation myocardial infarction.
  • To assess the predictive value of these methods in conjunction with pharmacologic agents.

Main Methods:

  • Review of current and future risk stratification techniques.
  • Analysis of predictive values of risk markers in relation to pharmacologic therapies.

Main Results:

  • Most data supporting pharmacologic regimens in high-risk patients are retrospective.

Related Experiment Videos

  • No definitive prospective studies currently guide therapy based on risk markers.

    • Conclusions:

    • Clinicians must understand risk markers for unstable angina and non-ST segment elevation myocardial infarction.
    • Familiarity with risk markers is crucial for applying appropriate management strategies, including pharmacologic therapy.